 | • レポートコード：QY20ST-02311 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器・消耗品 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の双極性障害治療薬市場について種類別（オランザピン（ジプレキサ）、ケチアピン（セロクエル）、リスペリドン（リスペルダル）、アリプラゾール（エビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザリル））、用途別（ルマテペロン、中枢神経系（CNS）障害）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・双極性障害治療薬市場の概要 ・世界の主要地域別双極性障害治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の双極性障害治療薬市場規模2015-2026：種類別（オランザピン（ジプレキサ）、ケチアピン（セロクエル）、リスペリドン（リスペルダル）、アリプラゾール（エビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザリル）） ・世界の双極性障害治療薬市場規模2015-2026：用途別（ルマテペロン、中枢神経系（CNS）障害） ・双極性障害治療薬の北米市場規模2015-2020 ・双極性障害治療薬のヨーロッパ市場規模2015-2020 ・双極性障害治療薬の中国市場規模2015-2020 ・双極性障害治療薬の日本市場規模2015-2020 ・双極性障害治療薬の東南アジア市場規模2015-2020 ・双極性障害治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・双極性障害治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・双極性障害治療薬の市場動向・機会・課題 ・調査の結論 |
Bipolar disorder, also known as manic-depressive disorder, is a combination of manic, hypomanic and depressive episodes.The ultimate goal of therapeutic agents for bipolar disorder is to improve patients’ quality of life and maintain good social function as much as possible.
Market Analysis and Insights: Global Bipolar Disorder Therapeutics Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bipolar Disorder Therapeutics Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Bipolar Disorder Therapeutics Drugs industry.
Based on our recent survey, we have several different scenarios about the Bipolar Disorder Therapeutics Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Bipolar Disorder Therapeutics Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Bipolar Disorder Therapeutics Drugs Scope and Market Size
The global Bipolar Disorder Therapeutics Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bipolar Disorder Therapeutics Drugs market is segmented into
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ariprazole (Abilify)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Segment by Application, the Bipolar Disorder Therapeutics Drugs market is segmented into
lumateperone
Central Nervous System (CNS) Disorders
The Bipolar Disorder Therapeutics Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Bipolar Disorder Therapeutics Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bipolar Disorder Therapeutics Drugs Market Share Analysis
Bipolar Disorder Therapeutics Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bipolar Disorder Therapeutics Drugs business, the date to enter into the Bipolar Disorder Therapeutics Drugs market, Bipolar Disorder Therapeutics Drugs product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals
1 Bipolar Disorder Therapeutics Drugs Market Overview
1.1 Bipolar Disorder Therapeutics Drugs Product Scope
1.2 Bipolar Disorder Therapeutics Drugs Segment by Type
1.2.1 Global Bipolar Disorder Therapeutics Drugs Sales by Type (2020-2026)
1.2.2 Olanzapine (Zyprexa)
1.2.3 Quetiapine (Seroquel)
1.2.4 Risperidone (Risperdal)
1.2.5 Ariprazole (Abilify)
1.2.6 Ziprasidone (Geodon)
1.2.7 Clozapine (Clozaril)
1.3 Bipolar Disorder Therapeutics Drugs Segment by Application
1.3.1 Global Bipolar Disorder Therapeutics Drugs Sales Comparison by Application (2020-2026)
1.3.2 lumateperone
1.3.3 Central Nervous System (CNS) Disorders
1.4 Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Bipolar Disorder Therapeutics Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Bipolar Disorder Therapeutics Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Bipolar Disorder Therapeutics Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Bipolar Disorder Therapeutics Drugs Industry
1.5.1.1 Bipolar Disorder Therapeutics Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Bipolar Disorder Therapeutics Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Bipolar Disorder Therapeutics Drugs Players to Combat Covid-19 Impact
2 Bipolar Disorder Therapeutics Drugs Estimate and Forecast by Region
2.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Bipolar Disorder Therapeutics Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Bipolar Disorder Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Bipolar Disorder Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.3 China Bipolar Disorder Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Bipolar Disorder Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Bipolar Disorder Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.6 India Bipolar Disorder Therapeutics Drugs Estimates and Projections (2015-2026)
3 Global Bipolar Disorder Therapeutics Drugs Competition Landscape by Players
3.1 Global Top Bipolar Disorder Therapeutics Drugs Players by Sales (2015-2020)
3.2 Global Top Bipolar Disorder Therapeutics Drugs Players by Revenue (2015-2020)
3.3 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2019)
3.4 Global Bipolar Disorder Therapeutics Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Bipolar Disorder Therapeutics Drugs Players (Opinion Leaders)
4 Global Bipolar Disorder Therapeutics Drugs Market Size by Type
4.1 Global Bipolar Disorder Therapeutics Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2014-2020)
4.2 Global Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2021-2026)
5 Global Bipolar Disorder Therapeutics Drugs Market Size by Application
5.1 Global Bipolar Disorder Therapeutics Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Bipolar Disorder Therapeutics Drugs Price by Application (2015-2020)
5.2 Global Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2021-2026)
3 North America Bipolar Disorder Therapeutics Drugs Market Facts & Figures
3.2 North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
3.3 North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
3.4 North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
4 Europe Bipolar Disorder Therapeutics Drugs Market Facts & Figures
4.2 Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
5 China Bipolar Disorder Therapeutics Drugs Market Facts & Figures
5.2 China Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
5.3 China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
5.4 China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
6 Japan Bipolar Disorder Therapeutics Drugs Market Facts & Figures
6.2 Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Bipolar Disorder Therapeutics Drugs Market Facts & Figures
7.2 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
8 India Bipolar Disorder Therapeutics Drugs Market Facts & Figures
8.2 India Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
8.3 India Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
8.4 India Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Bipolar Disorder Therapeutics Drugs Business
12.1 AstraZeneca
12.1.1 AstraZeneca Bipolar Disorder Therapeutics Drugs Corporation Information
12.1.2 AstraZeneca Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Allergan
12.2.1 Allergan Bipolar Disorder Therapeutics Drugs Corporation Information
12.2.2 Allergan Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Bipolar Disorder Therapeutics Drugs Products Offered
12.2.5 Allergan Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Corporation Information
12.3.2 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 GSK
12.4.1 GSK Bipolar Disorder Therapeutics Drugs Corporation Information
12.4.2 GSK Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GSK Bipolar Disorder Therapeutics Drugs Products Offered
12.4.5 GSK Recent Development
12.5 Janssen
12.5.1 Janssen Bipolar Disorder Therapeutics Drugs Corporation Information
12.5.2 Janssen Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Janssen Bipolar Disorder Therapeutics Drugs Products Offered
12.5.5 Janssen Recent Development
12.6 AbbVie
12.6.1 AbbVie Bipolar Disorder Therapeutics Drugs Corporation Information
12.6.2 AbbVie Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Products Offered
12.6.5 AbbVie Recent Development
12.7 Youdim
12.7.1 Youdim Bipolar Disorder Therapeutics Drugs Corporation Information
12.7.2 Youdim Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.7.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Youdim Bipolar Disorder Therapeutics Drugs Products Offered
12.7.5 Youdim Recent Development
12.8 Delpor
12.8.1 Delpor Bipolar Disorder Therapeutics Drugs Corporation Information
12.8.2 Delpor Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Delpor Bipolar Disorder Therapeutics Drugs Products Offered
12.8.5 Delpor Recent Development
12.9 Lundbeck
12.9.1 Lundbeck Bipolar Disorder Therapeutics Drugs Corporation Information
12.9.2 Lundbeck Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Products Offered
12.9.5 Lundbeck Recent Development
12.10 Intra-Cellular Therapies
12.10.1 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Corporation Information
12.10.2 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Products Offered
12.10.5 Intra-Cellular Therapies Recent Development
12.11 Novartis Pharmaceuticals Corporation
12.11.1 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Corporation Information
12.11.2 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Products Offered
12.11.5 Novartis Pharmaceuticals Corporation Recent Development
12.12 Noven Pharmaceuticals
12.12.1 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Corporation Information
12.12.2 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Products Offered
12.12.5 Noven Pharmaceuticals Recent Development
12.13 Otsuka
12.13.1 Otsuka Bipolar Disorder Therapeutics Drugs Corporation Information
12.13.2 Otsuka Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Products Offered
12.13.5 Otsuka Recent Development
12.14 Pfizer
12.14.1 Pfizer Bipolar Disorder Therapeutics Drugs Corporation Information
12.14.2 Pfizer Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Products Offered
12.14.5 Pfizer Recent Development
12.15 Reviva Pharmaceuticals
12.15.1 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Corporation Information
12.15.2 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Business Overview and Total Revenue
12.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Products Offered
12.15.5 Reviva Pharmaceuticals Recent Development
13 Bipolar Disorder Therapeutics Drugs Manufacturing Cost Analysis
13.1 Bipolar Disorder Therapeutics Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
13.4 Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bipolar Disorder Therapeutics Drugs Distributors List
14.3 Bipolar Disorder Therapeutics Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Bipolar Disorder Therapeutics Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Bipolar Disorder Therapeutics Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Bipolar Disorder Therapeutics Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Bipolar Disorder Therapeutics Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Region (2015-2020)
Table 13. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Bipolar Disorder Therapeutics Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Bipolar Disorder Therapeutics Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Bipolar Disorder Therapeutics Drugs Sales Share by Company (2015-2020)
Table 19. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Company (2015-2020)
Table 21. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2019)
Table 22. Global Bipolar Disorder Therapeutics Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Bipolar Disorder Therapeutics Drugs Players
Table 27. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2015-2020)
Table 29. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Bipolar Disorder Therapeutics Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2021-2026)
Table 32. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2021-2026)
Table 34. Global Bipolar Disorder Therapeutics Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2015-2020)
Table 37. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Bipolar Disorder Therapeutics Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2021-2026)
Table 41. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2021-2026)
Table 43. Global Bipolar Disorder Therapeutics Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 56. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 58. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 60. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 74. India Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 76. India Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 78. India Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AstraZeneca Bipolar Disorder Therapeutics Drugs Product
Table 84. AstraZeneca Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Allergan Bipolar Disorder Therapeutics Drugs Product
Table 89. Allergan Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GSK Bipolar Disorder Therapeutics Drugs Product
Table 99. GSK Recent Development
Table 100. Janssen Corporation Information
Table 101. Janssen Description and Business Overview
Table 102. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Janssen Bipolar Disorder Therapeutics Drugs Product
Table 104. Janssen Recent Development
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Business Overview
Table 107. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. AbbVie Bipolar Disorder Therapeutics Drugs Product
Table 109. AbbVie Recent Development
Table 110. Youdim Corporation Information
Table 111. Youdim Description and Business Overview
Table 112. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Youdim Bipolar Disorder Therapeutics Drugs Product
Table 114. Youdim Recent Development
Table 115. Delpor Corporation Information
Table 116. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Delpor Description and Business Overview
Table 118. Delpor Bipolar Disorder Therapeutics Drugs Product
Table 119. Delpor Recent Development
Table 120. Lundbeck Corporation Information
Table 121. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Lundbeck Description and Business Overview
Table 123. Lundbeck Bipolar Disorder Therapeutics Drugs Product
Table 124. Lundbeck Recent Development
Table 125. Intra-Cellular Therapies Corporation Information
Table 126. Intra-Cellular Therapies Description and Business Overview
Table 127. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product
Table 129. Intra-Cellular Therapies Recent Development
Table 130. Novartis Pharmaceuticals Corporation Corporation Information
Table 131. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 132. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product
Table 134. Novartis Pharmaceuticals Corporation Recent Development
Table 135. Noven Pharmaceuticals Corporation Information
Table 136. Noven Pharmaceuticals Description and Business Overview
Table 137. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product
Table 139. Noven Pharmaceuticals Recent Development
Table 140. Otsuka Corporation Information
Table 141. Otsuka Description and Business Overview
Table 142. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Otsuka Bipolar Disorder Therapeutics Drugs Product
Table 144. Otsuka Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer Description and Business Overview
Table 147. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Pfizer Bipolar Disorder Therapeutics Drugs Product
Table 149. Pfizer Recent Development
Table . Reviva Pharmaceuticals Corporation Information
Table . Reviva Pharmaceuticals Description and Business Overview
Table . Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product
Table . Reviva Pharmaceuticals Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Bipolar Disorder Therapeutics Drugs Distributors List
Table 158. Bipolar Disorder Therapeutics Drugs Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture
Figure 2. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bipolar Disorder Therapeutics Drugs Market Share by Application in 2020 & 2026
Figure 6. lumateperone Examples
Figure 7. Central Nervous System (CNS) Disorders Examples
Figure 8. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Bipolar Disorder Therapeutics Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Bipolar Disorder Therapeutics Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Bipolar Disorder Therapeutics Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Bipolar Disorder Therapeutics Drugs Players Market Share by Revenue in Bipolar Disorder Therapeutics Drugs 2015 & 2019
Figure 26. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Bipolar Disorder Therapeutics Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Bipolar Disorder Therapeutics Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 32. United States Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 33. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Company in 2019
Figure 34. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 35. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2019
Figure 36. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Company in 2019
Figure 37. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 38. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2019
Figure 39. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Company in 2019
Figure 40. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 41. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2019
Figure 45. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Company in 2019
Figure 46. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2019
Figure 47. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2019
Figure 48. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Youdim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Delpor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Intra-Cellular Therapies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Novartis Pharmaceuticals Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Noven Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Reviva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Bipolar Disorder Therapeutics Drugs
Figure 65. Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs
Figure 66. Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
注意欠陥多動性障害（ADHD）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global ma…- 脊髄炎視神経スペクトラム障害治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Neuromyelitis Optic Spectrum Disorder Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 中枢神経系障害治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Central Nervous System Disorders Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…
- オピオイド使用障害および薬物中毒治療用医療機器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic …
- 異食症摂食障害用治療の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Pica Eating Disorder Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…